Perbedaan Organon Pharma Indonesia Tbk. dan Widodo Makmur Perkasa Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Widodo Makmur Perkasa Tbk. diperdagangkan di Rp30 (kapitalisasi pasar 853,15 M, volume 24 jam 31,14 jt). Perbedaan utamanya: Widodo Makmur Perkasa Tbk. jauh lebih besar — sekitar 8,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WMPP | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 853,15 M |
Volume | — | 31,14 jt |
Lot | — | 311,36 rb |
Perputaran | — | 929,07 jt |
Harga Rata-rata | — | 29,84 |
Nilai Transaksi | — | 929,07 jt |
Harga Ekuilibrium Indikatif | — | 30 |
Volume Ekuilibrium Indikatif | — | 130,05 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Widodo Makmur Perkasa Tbk (the Company) was established based on Notarial Deed No. 1 dated April 1, 2003 of Notary Durachman, S.H. The ultimate controlling shareholder of the Company is Mr. Tumiyana. The company commenced commercial operations in April 1, 2003
Selengkapnya di halaman WMPP →